Clinical Trials Browser

INDUSTRY × Thyroid Neoplasms × surufatinib × Clear all

NCT02614495 2020-02-13

Study of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyroid Carcinoma

Phase 2 Completed

Thyroid Neoplasms